Kristyn Beck1, Joan Paul2, Shilpa Sawardekar3, Valerie Harvey4. 1. Eastern Virginia Medical School, Department of Internal Medicine, 700 West Olney Road, Norfolk, VA, 23507, USA; 2. Dartmouth Hitchcock Medical Center, Section of Dermatology, 18 Old Etna Road, Lebanon, NH, 03756, USA; 3. Eastern Virginia Medical School, Department of Dermatology, 721 Fairfax Avenue, Suite 200, Norfolk, VA, 23507, USA; 4. Eastern Virginia Medical School, Department of Dermatology, 721 Fairfax Avenue, Suite 200, Norfolk, VA, 23507, USA; ; Hampton University Skin of Color Research Institute, Hampton University, Hampton, VA, USA.
Abstract
BACKGROUND: Hepatitis C viral infection is a significant public health problem; 170 million persons are infected worldwide and the prevalence in the southern part of the United States exceeds two percent. Extrahepatic manifestations of hepatitis C viral infection are common; notably, 15-20% of patients will develop cutaneous manifestations of their disease. There are numerous dermatologic diseases associated with hepatitis C infection, including lichen planus, leukocytoclasticvasculitis, and porphyria cutaneatarda. MAIN OBSERVATION: Recently, epidemiological studies have also demonstrated an association between hepatitis C infection and the development of non-Hodgkin lymphoma, especially marginal zone B-cell lymphoma. Herein we report the unusual case of a systemic marginal zone lymphoma in a patient with hepatitis C infection presenting clinically as localized lipoatrophy. CONCLUSIONS: Lipoatrophy can be a rare and diagnostically challenging presentation of secondary cutaneous marginal zone B-cell lymphoma. The importance of early recognition and detection cannot be over emphasized, as new and effective anti-viral treatments can lead to lymphoma regression in up to 75% of patients. To our knowledge, this is the first case of hepatitis C viral infection associated marginal zone lymphoma to present as localized lipoatrophy.
BACKGROUND:Hepatitis C viral infection is a significant public health problem; 170 million persons are infected worldwide and the prevalence in the southern part of the United States exceeds two percent. Extrahepatic manifestations of hepatitis C viral infection are common; notably, 15-20% of patients will develop cutaneous manifestations of their disease. There are numerous dermatologic diseases associated with hepatitis C infection, including lichen planus, leukocytoclasticvasculitis, and porphyria cutaneatarda. MAIN OBSERVATION: Recently, epidemiological studies have also demonstrated an association between hepatitis C infection and the development of non-Hodgkin lymphoma, especially marginal zone B-cell lymphoma. Herein we report the unusual case of a systemic marginal zone lymphoma in a patient with hepatitis C infection presenting clinically as localized lipoatrophy. CONCLUSIONS: Lipoatrophy can be a rare and diagnostically challenging presentation of secondary cutaneous marginal zone B-cell lymphoma. The importance of early recognition and detection cannot be over emphasized, as new and effective anti-viral treatments can lead to lymphoma regression in up to 75% of patients. To our knowledge, this is the first case of hepatitis C viral infection associated marginal zone lymphoma to present as localized lipoatrophy.
Authors: Pedram Gerami; Scott C Wickless; Christiane Querfeld; Steven T Rosen; Timothy M Kuzel; Joan Guitart Journal: J Am Acad Dermatol Date: 2010-05-11 Impact factor: 11.527
Authors: Y Peñate; B Hernández-Machín; L I Pérez-Méndez; F Santiago; B Rosales; O Servitje; T Estrach; M Fernández-Guarino; L Calzado; E Acebo; F Gallardo; A Salar; R Izu; P L Ortiz-Romero; R M Pujol; R Fernández-de-Misa Journal: Br J Dermatol Date: 2012-07 Impact factor: 9.302
Authors: M Paulli; L Arcaini; M Lucioni; E Boveri; D Capello; F Passamonti; M Merli; S Rattotti; D Rossi; R Riboni; E Berti; U Magrini; R Bruno; G Gaidano; M Lazzarino Journal: Ann Oncol Date: 2009-10-25 Impact factor: 32.976
Authors: Rein Willemze; Patty M Jansen; Lorenzo Cerroni; Emilio Berti; Marco Santucci; Chalid Assaf; Marijke R Canninga-van Dijk; Agnes Carlotti; Marie-Louise Geerts; Sonja Hahtola; Michael Hummel; Leila Jeskanen; Werner Kempf; Cesare Massone; Pablo L Ortiz-Romero; Marco Paulli; Tony Petrella; Annamari Ranki; José L Rodriguez Peralto; Alistair Robson; Nancy J Senff; Maarten H Vermeer; Janine Wechsler; Sean Whittaker; Chris J L M Meijer Journal: Blood Date: 2007-10-12 Impact factor: 22.113